Which has stronger evidence, MDMA-Assisted Therapy or Psilocybin-Assisted Therapy?

MDMA-Assisted Therapy is rct-supported; Psilocybin-Assisted Therapy is guideline-recommended.

MDMA-Assisted Therapy vs Psilocybin-Assisted Therapy

Q: What's the difference between MDMA-Assisted Therapy and Psilocybin-Assisted Therapy?

MDMA-Assisted Therapy works by MDMA reduces fear response and increases trust/empathy, enabling deeper trauma processing within therapeutic relationship Psilocybin-Assisted Therapy, by contrast, works by Psilocybin disrupts default mode network rigidity; mystical-type experiences occasion lasting shifts in perspective and meaning MDMA-Assisted Therapy sits within the Psychedelic tradition; Psilocybin-Assisted Therapy sits within the Psychedelic tradition.

A side-by-side comparison: mechanism, evidence, the conditions each treats, philosophical roots, and where they actually disagree clinically.

At a glance

MDMA-Assisted Therapy

Tradition: Psychedelic
Founder: MAPS / Mithoefer (2021)
Evidence: RCT-supported
Focus: Experiential + Processing
Format: Individual (co-therapist)
Duration: Short (3 sessions)

Psilocybin-Assisted Therapy

Tradition: Psychedelic
Founder: Griffiths / Carhart-Harris (2016)
Evidence: Guideline-recommended
Focus: Experiential + Processing
Format: Individual
Duration: Short (1-3 doses)

How they work

MDMA-Assisted Therapy

Core mechanism: MDMA reduces fear response and increases trust/empathy, enabling deeper trauma processing within therapeutic relationship

Ontology: PTSD maintained by overwhelming fear that prevents therapeutic engagement; MDMA lowers this barrier pharmacologically

Psilocybin-Assisted Therapy

Core mechanism: Psilocybin disrupts default mode network rigidity; mystical-type experiences occasion lasting shifts in perspective and meaning

Ontology: Rigid self-referential processing (depression) or compulsive patterns maintained by entrenched neural networks

Conditions treated

0 shared · 2 MDMA-Assisted Therapy-only · 3 Psilocybin-Assisted Therapy-only

Only MDMA-Assisted Therapy

PTSD & Acute Trauma Complex Trauma / Developmental Trauma

Only Psilocybin-Assisted Therapy

Depression & Mood Disorders Substance Use & Addictions Existential & Meaning-Making Concerns

What each assumes — and misses

MDMA-Assisted Therapy

Philosophical roots: Mithoefer (inner healing intelligence); Rogers (organismic wisdom, given conditions); Buber (I-Thou enabled pharmacologically); trauma processing theory

Blind spots: FDA declined approval (2024); methodological concerns about unblinding; not currently legally available outside research

Therapeutic voice: You're safe here. If something difficult comes up, you can move toward it — you don't have to do this alone.

Psilocybin-Assisted Therapy

Philosophical roots: James (mystical experience); Huxley (doors of perception, reducing valve theory); Watts (ego dissolution); Buddhist concepts (non-self, interconnection); Carhart-Harris (entropic brain hypothesis)

Blind spots: Not FDA approved; challenging experiences can be destabilizing; standardization of therapy component still developing

Therapeutic voice: Whatever comes, let it come. Whatever goes, let it go. Trust the process.

Choosing between them

MDMA-Assisted Therapy and Psilocybin-Assisted Therapy both sit within the Psychedelic tradition — they share a worldview about what suffering is and how change happens. Differences are more often about technique and emphasis than about underlying theory.

For deeper coverage: see the full MDMA-Assisted Therapy and Psilocybin-Assisted Therapy pages, or use the interactive comparison tool to add more modalities to this comparison.